# Aggressive Basal Cell Carcinoma With Rib Metastasis: An Uncommon Presentation of a Common Skin Cancer

**Authors:** Junu Giri, Ammar Al Heyasat, Sandesh Neupane, Maida S Chaudhry, Indira Poojary

PMC · DOI: 10.7759/cureus.85762 · Cureus · 2025-06-11

## TL;DR

A rare case of aggressive basal cell carcinoma with rib metastasis highlights the importance of early detection and multidisciplinary treatment.

## Contribution

Reports a rare case of metastatic BCC with rib involvement and successful multimodal treatment.

## Key findings

- BCC can become aggressive and metastatic if left untreated for long periods.
- Multimodal therapy including targeted and immunotherapy led to clinical improvement.
- Early detection is critical to prevent advanced BCC complications.

## Abstract

Basal cell carcinoma (BCC) is the most common skin cancer, generally characterized by slow growth and minimal risk of metastasis. However, in rare cases, particularly those left untreated for extended periods, BCC can become deeply invasive and even metastatic. We report the case of a 72-year-old woman with a long-neglected ulcerating facial tumor that was ultimately diagnosed as BCC with extensive local invasion and biopsy-proven metastasis to the left anterior fifth rib. Imaging revealed destruction of the maxilla, orbit, and palate. The patient was managed with a multimodal approach, including hedgehog pathway inhibition with vismodegib, immune checkpoint blockade with cemiplimab, palliative radiation therapy, and ultimately extensive surgical resection. The coordinated therapeutic response led to clinical improvement and disease stabilization. This case underscores the potential aggressiveness of neglected BCC and reinforces the value of early detection and comprehensive, multidisciplinary management in advanced presentations.

## Linked entities

- **Chemicals:** vismodegib (PubChem CID 24776445)
- **Diseases:** basal cell carcinoma (MONDO:0005341)

## Full-text entities

- **Diseases:** Skin Cancer (MESH:D012878), BCC (MESH:D002280), destruction of the maxilla, orbit, and palate (MESH:D009916), ulcerating facial tumor (MESH:D005153), Rib Metastasis (MESH:D009362)
- **Chemicals:** cemiplimab (MESH:C000627974), vismodegib (MESH:C538724)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12254075/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12254075/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12254075/full.md

---
Source: https://tomesphere.com/paper/PMC12254075